Mild Hypofractionated Radiation Therapy for Merkel Cell Carcinoma. 2020

Toshiaki Matsui, and Naoko Okano, and Hidemasa Kawamura, and Takahiro Oike, and Tatsuya Ohno
Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, JPN.

Merkel cell carcinoma (MCC) is an aggressive cutaneous neuroendocrine neoplasm. Although surgical resection is the first-line treatment for primary MCCs, the characteristics of this disease (i.e., high prevalence in the elderly and in the head and neck region) generate a considerable number of inoperable cases. Radiation therapy shows potential as a definitive treatment alternative to surgery. In definitive radiation therapy for non-resected MCC, 60-66 Gy administered in 2 Gy per fraction and five fractions per week is recommended. However, such frequent visits to the hospital can be a great burden to elderly patients and family members. In this report, we present the case of an 89-year-old patient with MCC (cT2N0M0, stage IIA) of the left cheek. The patient was treated with radiation therapy using a mild hypofractionated schedule (57 Gy provided in 3 Gy per fraction and three fractions per week) targeting the gross tumor. The treatment led to complete tumor remission with well-tolerated acute toxicities at three months post-irradiation. This case indicates that a mild hypofractionated irradiation schedule may achieve tumor control in MCC patients who are inoperable and who cannot make frequent hospital visits.

UI MeSH Term Description Entries

Related Publications

Toshiaki Matsui, and Naoko Okano, and Hidemasa Kawamura, and Takahiro Oike, and Tatsuya Ohno
January 2018, International journal of radiation oncology, biology, physics,
Toshiaki Matsui, and Naoko Okano, and Hidemasa Kawamura, and Takahiro Oike, and Tatsuya Ohno
March 1986, The American surgeon,
Toshiaki Matsui, and Naoko Okano, and Hidemasa Kawamura, and Takahiro Oike, and Tatsuya Ohno
January 2017, International journal of particle therapy,
Toshiaki Matsui, and Naoko Okano, and Hidemasa Kawamura, and Takahiro Oike, and Tatsuya Ohno
January 2018, International journal of radiation oncology, biology, physics,
Toshiaki Matsui, and Naoko Okano, and Hidemasa Kawamura, and Takahiro Oike, and Tatsuya Ohno
February 2024, Journal of the American Academy of Dermatology,
Toshiaki Matsui, and Naoko Okano, and Hidemasa Kawamura, and Takahiro Oike, and Tatsuya Ohno
May 2022, Clinical oncology (Royal College of Radiologists (Great Britain)),
Toshiaki Matsui, and Naoko Okano, and Hidemasa Kawamura, and Takahiro Oike, and Tatsuya Ohno
April 2010, Cancer,
Toshiaki Matsui, and Naoko Okano, and Hidemasa Kawamura, and Takahiro Oike, and Tatsuya Ohno
April 2010, Journal of feline medicine and surgery,
Toshiaki Matsui, and Naoko Okano, and Hidemasa Kawamura, and Takahiro Oike, and Tatsuya Ohno
September 1991, Cancer,
Toshiaki Matsui, and Naoko Okano, and Hidemasa Kawamura, and Takahiro Oike, and Tatsuya Ohno
December 2013, International journal of radiation oncology, biology, physics,
Copied contents to your clipboard!